Dale Sanders, Chief Technology Officer at Health Catalyst, Inc. (HCAT), sold 27,500 shares at $25.37 ($698K) on 2020-05-01, disclosed to the SEC on 2020-05-05.
Open-market sale of $698k HCAT by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| HCAT | SELL | 2020-07-06 | $795K | — | Filing → |
| HCAT | SELL | 2020-06-03 | $742K | — | Filing → |
| HCAT | SELL | 2020-04-03 | $1.4M | — | Filing → |